Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Bauer LM et al. | 2017 | microalga (<i>Chlorella kessleri</i>) | static magnetic field | - |
Prasad A et al. | 2017 | intact cell/cell culture, human oligodendrocytes precursor cells | static magnetic field | - |
Quiñones-Peña MA et al. | 2017 | bacterium, <i>Escherichia coli</i> (different strains) | static magnetic field | - |
Yamashita K et al. | 2001 | intact cell/cell culture, NG108-15 (the cells result from the fusion of N18TG-2 mouse neuroblastoma cells with C6BU-1 rat glioma cells) | static magnetic field | - |
Abbro L et al. | 2004 | intact cell/cell culture, human peripheral blood lymphocytes | static magnetic field | - |
Deamici KM et al. | 2017 | virus/bacteriophages, <i>Spirulina</i> sp. LEB 18 | static magnetic field | - |
Ben Mouhoub R et al. | 2018 | bacterium, <i>Salmonella enterica</i> subsp <i>enterica</i> serovar Hadar | static magnetic field | - |
Wosik J et al. | 2018 | intact cell/cell culture, murine peritoneal macrophages | static magnetic field | - |
Wang D et al. | 2018 | intact cell/cell culture, HeLa (human cervical carcinoma cell line), HCT116 (human colorectal cancer cells), MCF7 (human breast cancer cell line), A-431 (human epidermis cancer cells), A549 (human lung cancer cell line), U251 (human glioblastoma cell line), MV-4-11 (human peripheral blood cancer cells), GIST-T1 (human gastrointestinal stromal cancer cells), rat cancer cell lines (differentiated PC12, undifferentiated PC12 and C6) and non-cancer cell lines (RPE1 and CHO) | static magnetic field | - |
Lin SL et al. | 2019 | intact cell/cell culture, NK92-MI cells (human natural killer cell line) and K562 cells (human erythroleukemic cell line) | static magnetic field | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.